...
首页> 外文期刊>Brain research >Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord.
【24h】

Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord.

机译:鞘内注射白细胞介素1β可通过激活大鼠脊髓中可诱导的一氧化氮合酶表达来诱导热痛觉过敏。

获取原文
获取原文并翻译 | 示例
           

摘要

The effect of the pro-inflammatory cytokine interleukin-1beta (IL-1beta) on the inducible nitric oxide synthase-nitric oxide (iNOS-NO) cascade in nociceptive signal transduction was examined in the intact rat spinal cord. All rats were implanted with an intrathecal (i.t.) catheter; some were also implanted with an i.t. microdialysis probe. The paw withdrawal latency to radiant heat was used to assess thermal hyperalgesia. The iNOS protein expression in the spinal cord dorsal horn was examined by western blot analysis and NOS activity assay. NO production in the CSF dialysate was also measured. IL-1beta i.t. (100 ng) produced thermal hyperalgesia from 4 to 24 h after i.t. injection. The iNOS protein expression was induced at 4 h after i.t. IL-1beta injection, peaked at the 6th hour, and disappeared at 24 h. The iNOS activity showed a similar time-dependent change as the iNOS protein expression. NO release increased by 1.1- to 1.9-fold between 4 and 12 h, also with a peak at the 6th hour, after i.t. IL-1beta administration. Pretreatment with the iNOS inhibitor 1400W (10 microg, i.t.) 1 h before i.t. IL-1beta injection prevented all the responses of IL-1beta. Neither 1400W nor artificial CSF (aCSF) affected the thermal nociceptive threshold and NO production. These results demonstrate that i.t. administration of IL-1beta induced thermal hyperalgesia by activating the iNOS-NO cascade in the rat spinal cord. On the basis of the present findings, we suggest that i.t. administration of iNOS inhibitors may have potential in the treatment of inflammatory and neuropathic pain syndromes.
机译:在完整的大鼠脊髓中检查促炎性细胞因子白介素1β(IL-1β)对伤害性信号传导中诱导型一氧化氮合酶一氧化氮(iNOS-NO)级联的影响。所有大鼠均植入鞘内(i.t.)导管;有些还植入了i.t.微透析探针。爪子对辐射热量的潜伏潜伏期用于评估热痛觉过敏。通过蛋白质印迹分析和NOS活性测定法检查脊髓背角中iNOS蛋白的表达。还测量了CSF透析液中没有NO的产生。白介素1β i.t.后4至24小时(100 ng)产生热痛觉过敏注射。在i.t.后4小时诱导iNOS蛋白表达。 IL-1β注射在第6小时达到峰值,并在24 h时消失。 iNOS活性显示出与iNOS蛋白表达相似的时间依赖性变化。在i.t.之后的4至12小时之间,NO释放增加了1.1到1.9倍,并且在第6小时达到峰值。 IL-1beta管理。在i.t.治疗前1小时用iNOS抑制剂1400W(10 microg,i.t.)进行预处理。 IL-1beta注射阻止了IL-1beta的所有反应。 1400W和人工CSF(aCSF)都不会影响热伤害感受阈值和NO的产生。这些结果表明通过激活大鼠脊髓中的iNOS-NO级联,给予IL-1β诱导的热痛觉过敏。根据目前的发现,我们建议服用iNOS抑制剂可能具有治疗炎性和神经性疼痛综合征的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号